WHO ARE WE?

Our company includes staff with extensive practical experience in consulting, retail and hospital pharmacy, pharmaceutical sales and marketing, forecasting modeling and market research.

Our Principals

Rob MacLennanRob MacLennan, MBA, MA has experience working for several multinational pharmaceutical companies and a leading international market research company. His decision to start PharmAnalytics was based on a clear need for an experienced firm to provide more accurate modeling solutions for pharmaceutical clients. Over the years he has led over 100 assignments from a diverse client group and thoroughly enjoys the challenge each new project brings.

Rob MacLennanWingrove Carmichael, MBA, B.Sc. has experience in both finance and market analysis capacities. He has prepared detailed forecasts models for the Canadian diabetes, erectile dysfunction and cardiovascular drug therapy markets. Wingrove has over 20 years experience in employment, consulting and teaching in the business world. He is a focused implementer of business improvement projects and has demonstrated the ability to get things done. His experience includes working as a consultant for Ernst & Young, as a Finance Manager for GlaxoSmithKline, an adjunct Professor at Seneca College teaching courses in finance, marketing and statistics at Seneca College and as Director of Finance for a non profit.

Rob MacLennanJane Ascroft, B.Sc, Pharm, D. has over 20 years hospital and retail pharmacy experience.  Her market knowledge has proven invaluable in profiding unique insights into key pharmaceutical markets.

 

 

PharmAnalytics also relies on professionals with extensive experience in Microsoft Excel and Access programming.

"I hired PharmAnalytics on a number of projects which involved addressing specific questions we had about the impact of specific market events. PharmAnalytics were able to prepare a well-researched and user-friendly model which quickly provided the answers we were seeking. I highly recommend this company to anyone in the industry that is seeking to improve their forecasting modeling."

Sri Adapa Global Product Director
Neurology, Unit Neurosciences
Solvay Pharmaceuticals GmbH
Germany